TRANSFORMING GROWTH-FACTOR-BETA-1, A MAJOR STIMULATOR OF HYALURONAN SYNTHESIS IN HUMAN SYNOVIAL LINING CELLS

被引：57

作者：

HAUBECK, HD

KOCK, R

FISCHER, DC

VANDELEUR, E

HOFFMEISTER, K

GREILING, H

机构：

[1] University of Technology RWTH, Aachen

来源：

ARTHRITIS AND RHEUMATISM | 1995年 / 38卷 / 05期

关键词：

D O I：

10.1002/art.1780380515

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective. To investigate the role of cytokines and growth factors in the regulation of hyaluronan synthesis in human synovial lining cells, Methods. Synovial lining cells were obtained from human knee joints, isolated by the explant method, and characterized by immunocytochemistry using monoclonal antibodies against monocyte/macrophage markers as well as antibodies against hyaluronan synthase, After stimulation by cytokines and growth factors, hyaluronan was measured by radiometric assay. The molecular weight distribution of the hyaluronan synthesized was determined by high-performance gel-permeation liquid chromatography, To test the effect of oxygen-derived free radicals, the concentration and molecular weight distribution of hyaluronan were determined in the presence and absence of catalase and superoxide dismutase. Results. Hyaluronan synthesis was stimulated in synovial lining cells by transforming growth factor beta 1 (TGF beta 1), interleukin-1 beta (IL-1 beta), and to a lesser extent by tumor necrosis factor alpha (TNF alpha), Analysis of the molecular weight distribution of hyaluronan after stimulation of synovial lining cells with TGF beta 1, IL-1 beta, and TNF alpha indicated that hyaluronan is synthesized in a high molecular weight form and might be degraded in the course of inflammatory processes by oxygen-derived free radicals. Conclusion. Our findings suggest that TGF beta 1 is a major stimulator of hyaluronan synthesis in human synovial lining cells and might be involved in the pathogenic mechanisms of joint swelling in inflammatory and degenerative joint diseases.

引用

页码：669 / 677

页数：9

共 54 条

[1]

Meyer KP, Smith EM, Dawson MH, The isolation of a mucopolysaccharide from synovial fluid, J Biol Chem, 128, pp. 319-327, (1939)

[2]

Ogston AG, Stanier JE, The physiological function of hyaluronic acid in synovial fluid: viscous, elastic and lubricant properties, J Physiol, 119, pp. 244-252, (1953)

[3]

Sundblad L, Glycosaminoglycans and glycoproteins in synovial fluid, The Amino Sugars, 2 A, (1965)

[4]

The Biology of Hyaluronan: Ciba Foundation Symposium 143, (1989)

[5]

Sledge CB, Biology of the joint, Textbook of Rheumatology, (1989)

[6]

Laurent U, Fraser JR, Engstrom A, Reed R, Dahl L, Laurent T, Catabolism of hyaluronan in the knee joint of the rabbit, Matrix, 12, pp. 130-136, (1992)

[7]

Laurent U, Fraser JR, Hyaluronan, FASEB J, 6, pp. 2397-2404, (1992)

[8]

Di Giovine F, Manson J, Nuki G, Duff G, The presence of tumour necrosis factor activity in synovial exudate fluids from patients with OA and RA, Br J Rheumatol, 25, pp. 108-112, (1986)

[9]

Fava RA, Olsen NJ, Keski-Oja J, Moses H, Pincus T, Active and latent forms of transforming growth factor β activity in synovial effusions, J Exp Med, 169, pp. 291-296, (1989)

[10]

Dinarello CA, Interleukin‐1 and interleukin‐1 antagonism, Blood, 77, pp. 1627-1652, (1991)

← 1 2 3 4 5 6 →